Prevalence of occult hepatitis B amongst Indian human immunodeficiency virus type 1 infected individuals-a pilot study.

[1]  A. Eslamifar,et al.  Occult Hepatitis B Virus Infection in Hemodialysis Patients With Isolated Hepatitis B Core Antibody: A Multicenter Study , 2010, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[2]  V. Sharp,et al.  Predictors of loss of hepatitis B surface antigen in HIV-infected patients. , 2010, World journal of gastroenterology.

[3]  Sarman Singh,et al.  Occult Hepatitis B Virus infection in ART-Naive HIV-Infected Patients seen at a Tertiary Care Centre in North India , 2010, BMC infectious diseases.

[4]  E. Rigopoulou,et al.  Prevalence of occult hepatitis B virus infection in haemodialysis patients from central Greece. , 2010, World journal of gastroenterology.

[5]  D. D. Cardoso,et al.  The underlying mechanisms for the ‘anti-HBc alone’ serological profile , 2010, Archives of Virology.

[6]  E. Ozaslan,et al.  Controversies about occult hepatitis B virus infection. , 2009, World journal of gastroenterology.

[7]  J. Allain,et al.  Transfusion-transmitted hepatitis B virus infection. , 2009, Journal of hepatology.

[8]  I. Tan,et al.  "Anti-HBc alone" in human immunodeficiency virus-positive and immuno-suppressed lymphoma patients. , 2009, World journal of gastroenterology.

[9]  L. Gesualdo,et al.  Occult HBV infection in hemodialysis setting is marked by presence of isolated antibodies to HBcAg and HCV. , 2009, Journal of nephrology.

[10]  K. Gibney,et al.  Isolated core antibody hepatitis B in sub‐Saharan African immigrants , 2008, Journal of medical virology.

[11]  I. Adewole,et al.  Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients. , 2008, Annals of hepatology.

[12]  K. Lahiri,et al.  Hepatitis B e Antigen Negative Chronic Hepatitis in Indian Patients : A Reality. , 2007, Medical journal, Armed Forces India.

[13]  J. Rockstroh,et al.  Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co‐infection: Clinically relevant or a diagnostic problem? , 2007, Journal of medical virology.

[14]  C. M. Martin,et al.  The Prevalence and Significance of Occult Hepatitis B Virus in a Prospective Cohort of HIV-Infected Patients , 2007, Journal of acquired immune deficiency syndromes.

[15]  P. Alm.  Coinfection of hepatitis B and hepatitis C virus in HIV-infected patients in south India , 2007 .

[16]  S. Nijhawan,et al.  Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission. , 2007, Tropical gastroenterology : official journal of the Digestive Diseases Foundation.

[17]  G. Siame.  Hepatitis B and hepatitis C prevalence in HIV positive pregnant women , 2006, Retrovirology.

[18]  T. Poynard,et al.  Coexistence of Hepatitis B Surface Antigen (HBs Ag) and Anti-HBs Antibodies in Chronic Hepatitis B Virus Carriers: Influence of “a” Determinant Variants , 2006, Journal of Virology.

[19]  N. Mishra,et al.  Prevalence of parenterally transmitted hepatitis viruses in clinically diagnosed cases of hepatitis. , 2005, Indian journal of medical microbiology.

[20]  A. Mocroft,et al.  Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort , 2005, AIDS.

[21]  M. Opravil,et al.  Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only , 2005, European Journal of Clinical Microbiology and Infectious Diseases.

[22]  J. Allain.  Occult hepatitis B virus infection. , 2004, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

[23]  V. Soriano,et al.  Lack of 'occult' hepatitis B virus infection in HIV-infected patients. , 2002, AIDS.

[24]  L. Piroth,et al.  Hepatitis B virus seroconversion in HIV-HBV coinfected patients treated with highly active antiretroviral therapy. , 2000, Journal of Acquired Immune Deficiency Syndromes.

[25]  M. Kane.  Global programme for control of hepatitis B infection. , 1995, Vaccine.